Terapia anticoagulante para el tratamiento del COVID-19 y su impacto en la cavidad oral: una revisión
DOI:
https://doi.org/10.33448/rsd-v11i9.32195Palabras clave:
Covid-19; Anticoagulantes; Factores de riesgo.Resumen
Fundamentos: A COVID-19 é uma doença inflamatória causó pelo SARS-CoV-2, na qual p paciente pode evoluir para um estado hipercoagulavel, necesitándose de terapia antitrombótica. Objetivos: Descrever dados da literatura sobre o uso de anticoagulantes como tratamiento para pacientes COVID-19 positivo y su repercussão na cavidade oral, os antiagregantes plaquetários e anticoagulantes utilizados para auxilio de tratamiento de pacientes COVID -positivo, os exames e marcadores que auxiliam a escolha da terapia a ser utilizada, así como observar o tratar y asociar ao riesgo de hemorragia oral. Metodología: Foi realizado um levantamiento bibliográfico no período de 2012 a 2021 na base de pesquisa BvSalud. Foram usó as palavras-chaves “ COVID ”, “anticoagulantes” e “fatores de risco” y seus correspondientes em inglês “ COVID ”, “anticoagulants e “riskfactors”. Results: Foram selecionados 128 artigos na BvSalud, após a leitura foram excluídos 68 artigos, restando 60 artigos that adentiam os critérios for revisão de literatura. Conclusión: A COVID -19 é uma patologia que age sobre os receptores ECA2, desencadeando uma resposta inflamatória e ativando a cascata de coagulação, exames hematológicos (D-dimero, fibrinogenio, ferritina, tempo de protrombina, interleucina-6 and Proteina-C- reativa) puede ser utilizado para evaluar o estado del paciente. Una decisión de iniciar una terapia anticoagulante o antiagregante deve ocorrer después de una evaluación de los marcadores. Tal terapia puede exacerbar sangramentos decorativos de traumas o no hay momento de intubação ou de úlceras preexistentes ou adquiridas después de admisión en UTI, una instalación do TET requiere cuidados especiales com a higiene oral del paciente, tendo em vista a maior susceptibilidade as infecções secundárias.
Citas
Abdelwahab, H. W., Shaltout, S. W., Sayed Ahmed, H. A., Fouad, A. M., Merrell, E., Riley, J. B., Salama, R., Abdelrahman, A. G., Darling, E., Fadel, G., Elfar, M. S. A., Sabry, K., Shah, J., Amin, H., Nieman, G. F., Mishriky, A., & Aiash, H. (2021). Acetylsalicylic Acid Compared with Enoxaparin for the Prevention of Thrombosis and Mechanical Ventilation in COVID-19 Patients: A Retrospective Cohort Study. Clinical Drug Investigation, 41(8), 723–732. https://doi.org/10.1007/s40261-021-01061-2
Al-Ani, F., Chehade, S., & Lazo-Langner, A. (2020). Thrombosis risk associated with COVID-19 infection. A scoping review. Thrombosis research, 192, 152–160. https://doi.org/10.1016/j.thromres.2020.05.039
Al-Bayaty, F. H., Baharudin, N., & Hassan, M. I. A. (2021). Impact of dental plaque control on the survival of ventilated patients severely affected by COVID-19 infection: An overview. Dental and Medical Problems, 58(3), 385–395. https://doi.org/10.17219/dmp/132979
Alijotas-Reig, J., Esteve-Valverde, E., Belizna, C., Selva-O’Callaghan, A., Pardos-Gea, J., Quintana, A., Mekinian, A., Anunciacion-Llunell, A., & Miró-Mur, F. (2020). Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Autoimmunity Reviews, 19(7), 102569. https://doi.org/10.1016/j.autrev.2020.102569
Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Nigoghossian, C. D., Ageno, W., Madjid, M., Guo, Y., Tang, L. V., Hu, Y., Giri, J., Cushman, M., Quéré, I., Dimakakos, E. P., Gibson, C. M., Lippi, G., Favaloro, E. J., & Fareed, J. (2020). COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. Journal of the American College of Cardiology, 75(23). https://doi.org/10.1016/j.jacc.2020.04.031
Bowsher, J., Boyle, S., & Griffiths, J. (n.d.). A review of the research evidence base for oral care procedures utilised by nurses A clinical effectiveness review. http://www.sigwales.org/wp-content/uploads/bowsher20boyle20griffiths201999.pdf
Brum, C. N., Zuge, S. S., Rangel, R. F., Freitas, H. M. B., & Pieszak, G. M (2015). Revisão narrativa da literatura: aspectos conceituais e metodológicos na construção do conhecimento da enfermagem. In: Lacerda, M. R., & Costenaro, R. G. S. Metodologias da pesquisa para a enfermagem e saúde. (1ª ed.): Moriá
Chocron, R., Duceau, B., Gendron, N., Ezzouhairi, N., Khider, L., Trimaille, A., Goudot, G., Weizman, O., Alsac, J. M., Pommier, T., Bory, O., Cellier, J., Philippe, A., Geneste, L., Ben Abdallah, I., Panagides, V., El Batti, S., Marsou, W., Juvin, P., Deney, A., Critical COVID-19 France investigators (2021). D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study. Archives of cardiovascular diseases, 114(5), 381–393. https://doi.org/10.1016/j.acvd.2021.02.003
Daughety, M. M., Morgan, A., Frost, E., Kao, C., Hwang, J., Tobin, R., Patel, B., Fuller, M., Welsby, I., & Ortel, T. L. (2020). COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy. Thrombosis research, 196, 483–485. https://doi.org/10.1016/j.thromres.2020.10.004
Dogra, S., Jain, R., Cao, M., Bilaloglu, S., Zagzag, D., Hochman, S., Lewis, A., Melmed, K., Hochman, K., Horwitz, L., Galetta, S., & Berger, J. (2020). Hemorrhagic stroke and anticoagulation in COVID-19. Journal of Stroke and Cerebrovascular Diseases, 29(8). https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104984
Emmerich, J. (2020). Venous thromboembolism and COVID-19 patients: An ongoing story. JMV-Journal de Médecine Vasculaire. https://doi.org/10.1016/j.jdmv.2020.12.001
Franco, J. B., Ribas, P. F., Valente Júnior, L. A. S., Matias, D. T., Varotto, B. L. R., Hamza, C. R., Araújo, J. F., & Peres, M. P. S. de M. (2020). Hospital Dentistry and Dental Care for Patients with Special Needs: Dental approach during COVID-19 Pandemic. Brazilian Dental Science, 23(2). https://doi.org/10.14295/bds.2020.v23i2.2243
García-Ortega, A., Oscullo, G., Calvillo, P., López-Reyes, R., Méndez, R., Gómez-Olivas, J. D., Bekki, A., Fonfría, C., Trilles-Olaso, L., Zaldívar, E., Ferrando, A., Anguera, G., Briones-Gómez, A., Reig-Mezquida, J. P., Feced, L., González-Jiménez, P., Reyes, S., Muñoz-Núñez, C. F., Carreres, A., Gil, R., & Martínez-García, M. Á. (2021). Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection. The Journal of infection, 82(2), 261–269. https://doi.org/10.1016/j.jinf.2021.01.003
Giannis, D., Allen, S. L., Tsang, J., Flint, S., Pinhasov, T., Williams, S., Tan, G., Thakur, R., Leung, C., Snyder, M., Bhatia, C., Garrett, D., Cotte, C., Isaacs, S., Gugerty, E., Davidson, A., Marder, G. S., Schnitzer, A., Goldberg, B., McGinn, T., & Spyropoulos, A. C. (2021). Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood, 137(20), 2838–2847. https://doi.org/10.1182/blood.2020010529
Gibson, C. M., Spyropoulos, A. C., Cohen, A. T., Hull, R. D., Goldhaber, S. Z., Yusen, R. D., Hernandez, A. F., Korjian, S., Daaboul, Y., Gold, A., Harrington, R. A., & Chi, G. (2017). The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification. TH open : companion journal to thrombosis and haemostasis, 1(1), e56–e65. https://doi.org/10.1055/s-0037-1603929
Godier, A., Clausse, D., Meslin, S., Bazine, M., Lang, E., Huche, F., Cholley, B., & Hamada, S. R. (2021). Major bleeding complications in critically ill patients with COVID-19 pneumonia. Journal of thrombosis and thrombolysis, 52(1), 18–21. https://doi.org/10.1007/s11239-021-02403-9
Görlinger, K., Dirkmann, D., Gandhi, A., & Simioni, P. (2020). COVID-19 associated coagulopathy and inflammatory response. Anesthesia & Analgesia, Publish Ahead of Print. https://doi.org/10.1213/ane.0000000000005147
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., & Xiao, Y. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497–506. https://doi.org/10.1016/s0140-6736(20)30183-5
Iba, T., Nisio, M. D., Levy, J. H., Kitamura, N., & Thachil, J. (2017). New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open, 7(9), e017046. https://doi.org/10.1136/bmjopen-2017-017046
Ji, Y. L., Wu, Y., Qiu, Z., Ming, H., Zhang, Y., Zhang, A. N., Leng, Y., & Xia, Z. Y. (2021). The Pathogenesis and Treatment of COVID-19: A System Review. Biomedical and Environmental Sciences, 34(1), 50–60. https://doi.org/10.3967/bes2021.007
Jiménez, D., de Miguel-Díez, J., Guijarro, R., Trujillo-Santos, J., Otero, R., Barba, R., Muriel, A., Meyer, G., Yusen, R. D., & Monreal, M. (2016). Trends in the Management and Outcomes of Acute Pulmonary Embolism. Journal of the American College of Cardiology, 67(2), 162–170. https://doi.org/10.1016/j.jacc.2015.10.060
Kahn, S. R., Lim, W., Dunn, A. S., Cushman, M., Dentali, F., Akl, E. A., Cook, D. J., Balekian, A. A., Klein, R. C., Le, H., Schulman, S., & Murad, M. H. (2012). Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141(2 Suppl), e195S–e226S. https://doi.org/10.1378/chest.11-2296
Kaya, H., Turan, Y., Tunalı, Y., Aydın, G. Ö., Yüce, N., Gürbüz, Ş., & Tosun, K. (2017). Effects of oral care with glutamine in preventing ventilator-associated pneumonia in neurosurgical intensive care unit patients. Applied Nursing Research, 33, 10–14. https://doi.org/10.1016/j.apnr.2016.10.006
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., Stevens, S. M., Vintch, J., Wells, P., Woller, S. C., & Moores, L. (2016). Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest, 149(2), 315–352. https://doi.org/10.1016/j.chest.2015.11.026
Khan, I. H., Savarimuthu, S., Leung, M. S. T., & Harky, A. (2020). The need to manage the risk of thromboembolism in COVID-19 patients. Journal of Vascular Surgery, 72(3), 799–804. https://doi.org/10.1016/j.jvs.2020.05.015
Klok, F. A., Kruip, M., van der Meer, N., Arbous, M. S., Gommers, D., Kant, K. M., Kaptein, F., van Paassen, J., Stals, M., Huisman, M. V., & Endeman, H. (2020). Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thrombosis research, 191, 148–150. https://doi.org/10.1016/j.thromres.2020.04.041
Li, W., Xu, Z., Xiang, H., Zhang, C., Guo, Y., & Xiong, J. (2021). Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status. Aging, 13(7), 9225–9242. https://doi.org/10.18632/aging.202769
Mant, M. J., O'Brien, B. D., Thong, K. L., Hammond, G. W., Birtwhistle, R. V., & Grace, M. G. (1977). Haemorrhagic complications of heparin therapy. Lancet (London, England), 1(8022), 1133–1135. https://doi.org/10.1016/s0140-6736(77)92388-1
Martin, T. A., Wan, D. W., Hajifathalian, K., Tewani, S., Shah, S. L., Mehta, A., Kaplan, A., Ghosh, G., Choi, A. J., Krisko, T. I., Fortune, B. E., Crawford, C. V., & Sharaiha, R. Z. (2020). Gastrointestinal Bleeding in Patients With Coronavirus Disease 2019: A Matched Case-Control Study. American Journal of Gastroenterology, 115(10), 1609–1616. https://doi.org/10.14309/ajg.0000000000000805
Miesbach, W., & Makris, M. (2020). COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Clinical and Applied Thrombosis/Hemostasis, 26, 107602962093814. https://doi.org/10.1177/1076029620938149
Moores, L. K., Tritschler, T., Brosnahan, S., Carrier, M., Collen, J. F., Doerschug, K., Holley, A. B., Jimenez, D., LeGal, G., Rali, P., & Wells, P. (2020). Prevention, Diagnosis, and Treatment of VTE in Patients With COVID-19. Chest. https://doi.org/10.1016/j.chest.2020.05.559
Moschonas, I. C., & Tselepis, A. D. (2021). SARS-CoV-2 infection and thrombotic complications: a narrative review. Journal of thrombosis and thrombolysis, 52(1), 111–123. https://doi.org/10.1007/s11239-020-02374-3
Mousavi, S., Moradi, M., Khorshidahmad, T., & Motamedi, M. (2015). Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review. Advances in Pharmacological Sciences, 2015, 1–14. https://doi.org/10.1155/2015/507151
Ornelas-Ricardo, D., & Jaloma-Cruz, A. R. (2020). Coronavirus Disease 2019: Hematological Anomalies and Antithrombotic Therapy. The Tohoku journal of experimental medicine, 251(4), 327–336. https://doi.org/10.1620/tjem.251.327
Pancaldi, E., Pascariello, G., Cimino, G., Cersosimo, A., Amore, L., Alghisi, F., Bernardi, N., Calvi, E., Lombardi, C. M., Vizzardi, E., & Metra, M. (2021). Thrombotic risk in patients with COVID-19. Reviews in cardiovascular medicine, 22(2), 277–286. https://doi.org/10.31083/j.rcm2202035
Paranjpe, I., Fuster, V., Lala, A., Russak, A. J., Glicksberg, B. S., Levin, M. A., Charney, A. W., Narula, J., Fayad, Z. A., Bagiella, E., Zhao, S., & Nadkarni, G. N. (2020). Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19. Journal of the American College of Cardiology, 76(1), 122–124. https://doi.org/10.1016/j.jacc.2020.05.001
Parks, A. L., Auerbach, A. D., Schnipper, J. L., Anstey, J. E., Sterken, D. G., Hecht, T. E. H., Fang, M. C., Vaughn, V. M., Dunn, A. S., Linker, A. S., Hunt, D. P., Choi, J. J., Brotman, D. J., Streiff, M. B., Mattison, M. L. P., Pappas, M. A., Greysen, S. R., Hemsey, D. F., Dapaah-Afriyie, K., & Ahuja, N. (2020). COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic. Thrombosis Research, 196, 355–358. https://doi.org/10.1016/j.thromres.2020.09.018
Piera Carbonell, A., Frías Vargas, M., García Vallejo, O., García Lerín, A., Cabrera Ferriols, M. A., Peiró Morant, J., & Carrasco Carrasco, E. (2020). COVID-19 y tromboprofilaxis: recomendaciones para nuestra práctica clínica en Atención Primaria. Semergen, 46(7), 479–486. https://doi.org/10.1016/j.semerg.2020.07.007
Porfidia, A., & Pola, R. (2020). Venous Thromboembolism and Heparin Use in COVID-19 Patients: Juggling between Pragmatic Choices, Suggestions of Medical Societies and the Lack of Guidelines. Journal of thrombosis and thrombolysis, 50(1), 68–71. https://doi.org/10.1007/s11239-020-02125-4
Schiaffino, S., Giacomazzi, F., Esseridou, A., Cozzi, A., Carriero, S., Mazzaccaro, D. P., Nano, G., Di Leo, G., Spagnolo, P., & Sardanelli, F. (2021). Pulmonary thromboembolism in coronavirus disease 2019 patients undergoing thromboprophylaxis. Medicine, 100(1), e24002. https://doi.org/10.1097/md.0000000000024002
Schulman, S., Hu, Y., & Konstantinides, S. (2020). Venous Thromboembolism in COVID-19. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0040-1718532
Socransky, S. S., Haffajee, A. D., Cugini, M. A., Smith, C., & Kent, R. L. (1998). Microbial complexes in subgingival plaque. Journal of Clinical Periodontology, 25(2), 134–144. https://doi.org/10.1111/j.1600-051x.1998.tb02419.x
Stillson, J. E., Bunch, C. M., Gillespie, L., Khan, R., Wierman, M., Pulvirenti, J., Phyu, H., Anderson, S., Al-Fadhl, M., Thomas, A. V., Kwaan, H. C., Moore, E., Moore, H., & Walsh, M. M. (2021). Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/s-0041-1723754
Tal, S., Spectre, G., Kornowski, R., & Perl, L. (2020). Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far? Acta Haematologica, 1–8. https://doi.org/10.1159/000508233
Tang, N., Li, D., Wang, X., & Sun, Z. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis, 18(4), 844–847. https://doi.org/10.1111/jth.14768
Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., Clark, C., & Iba, T. (2020). ISTH interim guidance on recognition and management of coagulopathy in COVID-19. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/jth.14810
Topcu, A. C., Ozturk-Altunyurt, G., Akman, D., Batirel, A., & Demirhan, R. (2021). Acute Limb Ischemia in Hospitalized COVID-19 Patients. Annals of vascular surgery, 74, 88–94. https://doi.org/10.1016/j.avsg.2021.03.003
Vazquez, S. R. (2020). Vascular Disease Patient Information Page: Direct oral anticoagulants – 2020 update. Vascular Medicine, 25(2), 196–199. https://doi.org/10.1177/1358863x19898262
Wichmann, D., Sperhake, J. P., Lütgehetmann, M., Steurer, S., Edler, C., Heinemann, A., Heinrich, F., Mushumba, H., Kniep, I., Schröder, A. S., Burdelski, C., de Heer, G., Nierhaus, A., Frings, D., Pfefferle, S., Becker, H., Bredereke-Wiedling, H., de Weerth, A., Paschen, H. R., Sheikhzadeh-Eggers, S., & Kluge, S. (2020). Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Annals of internal medicine, 173(4), 268–277. https://doi.org/10.7326/M20-2003
Yin, S., Huang, M., Li, D., & Tang, N. (2020). Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-020-02105-8
Zhang, J., Zhou, L., Yang, Y., Peng, W., Wang, W., & Chen, X. (2020). Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. The Lancet Respiratory Medicine, 8(3), e11–e12. https://doi.org/10.1016/S2213-2600(20)30071-0
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054–1062. https://doi.org/10.1016/s0140-6736(20)30566-3
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2022 Igor Almeida de Moura Barros; Gabriela De Morais Guerra Ferraz; Ully Dias Nascimento Tavora Cavalcanti
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Los autores que publican en esta revista concuerdan con los siguientes términos:
1) Los autores mantienen los derechos de autor y conceden a la revista el derecho de primera publicación, con el trabajo simultáneamente licenciado bajo la Licencia Creative Commons Attribution que permite el compartir el trabajo con reconocimiento de la autoría y publicación inicial en esta revista.
2) Los autores tienen autorización para asumir contratos adicionales por separado, para distribución no exclusiva de la versión del trabajo publicada en esta revista (por ejemplo, publicar en repositorio institucional o como capítulo de libro), con reconocimiento de autoría y publicación inicial en esta revista.
3) Los autores tienen permiso y son estimulados a publicar y distribuir su trabajo en línea (por ejemplo, en repositorios institucionales o en su página personal) a cualquier punto antes o durante el proceso editorial, ya que esto puede generar cambios productivos, así como aumentar el impacto y la cita del trabajo publicado.
